» Articles » PMID: 31540807

The Etiology of Peyronie's Disease: Pathogenesis and Genetic Contributions

Overview
Journal Sex Med Rev
Date 2019 Sep 22
PMID 31540807
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Peyronie's disease (PD) is a chronic fibrosing condition that contributes to penile deformity, curvature, and pain. Initial familial studies demonstrated potential genetic links to PD. Since that time, very few investigations have significantly advanced the science in this area. Hence, there is a large opportunity and significant need to better study the underlying genomics and pathogenesis of PD.

Aim: To summarize the current genomic literature relevant to PD.

Methods: A review was performed of all PubMed-indexed literature from 1970-2018 relating to the pathophysiology and genetics of PD. Key findings were categorically summarized to include epidemiology, risk factors, inheritance patterns, chromosomal instability, genetic associations, epigenetics, differential gene expression, and preclinical models of PD.

Main Outcome Measures: Summary of the current literature on the genetics of PD.

Results: PD is a common condition and has several known risk factors and comorbid disease associations. Although men with PD are believed to be genetically predisposed, there are likely several subtypes of the condition, each with varied pathophysiological disorders and contributing factors. Available data suggest that PD is associated with underlying genetic instability, including dysregulation of genes relating to fibrosis and cellular degradation, thus, resulting in abnormal plaque development and penile deformity. Preclinical models, including cell cultures and rat models, demonstrate several consistencies with PD clinical and histopathologic characteristics; however, an ideal model with spontaneous development of PD is lacking.

Conclusion: Based on limited data, PD likely represents a heterogeneous condition, with both heritable and environmentally-driven epigenetic factors contributing to its development and progression. However, there remains a significant gap in the literature on the underlying cause and pathophysiology of the condition, suggesting a substantial need for further investigation and study. Sharma KL, Alom M, Trost L. The Etiology of Peyronie's Disease: Pathogenesis and Genetic Contributions. Sex Med Rev 2020;8:314-323.

Citing Articles

Risk of childlessness in help-seeking men with Peyronie's disease-A Swedish longitudinal study.

Kuja-Halkola R, Henningsohn L, Zietsch B, Larsson H, Cederlof M PLoS One. 2025; 20(1):e0315948.

PMID: 39883718 PMC: 11781693. DOI: 10.1371/journal.pone.0315948.


Intralesional injection of hyaluronic acid compared with verapamil in acute phase of Peyronie's disease: A prospective randomized clinical trial.

Abdel Fattah A, Diab T, El-Dakhakhny A, El Hamshary S Arab J Urol. 2024; 22(4):206-211.

PMID: 39355797 PMC: 11441066. DOI: 10.1080/20905998.2024.2333583.


Vacuum Erection Device Plus Once-Daily Tadalafil Improve Clinical Outcomes after Extracorporeal Shock Wave Therapy in Men Affected by Erectile Dysfunction Associated with Peyronie's Disease.

DellAtti L, Slyusar V, Ronchi P, Cambise C Life (Basel). 2024; 14(9).

PMID: 39337945 PMC: 11432888. DOI: 10.3390/life14091162.


The Versatility of Collagen in Pharmacology: Targeting Collagen, Targeting with Collagen.

Revert-Ros F, Ventura I, Prieto-Ruiz J, Hernandez-Andreu J, Revert F Int J Mol Sci. 2024; 25(12).

PMID: 38928229 PMC: 11203716. DOI: 10.3390/ijms25126523.


Penile prosthesis implantation is safe and effective in Peyronie's disease patients with and without erectile dysfunction.

Moncada I, Krishnappa P, Zaccaro C, Fraile A, Romero-Otero J, Martinez-Salamanca J Int J Impot Res. 2024; 37(1):61-65.

PMID: 38909107 DOI: 10.1038/s41443-024-00938-y.